Central and peripheral molecular targets for antiobesity pharmacotherapy (Q30388865)

14 October 2017

Central and peripheral molecular targets for antiobesity pharmacotherapy (English)

1 reference

14 October 2017

0 references

0 references

M A Valentino

1 reference

14 October 2017

J E Lin

series ordinal

1 reference

14 October 2017

S A Waldman

series ordinal

1 reference

14 October 2017

language of work or name

English

0 references

publication date

5 May 2010

1 reference

Clinical Pharmacology & Therapeutics

14 October 2017

1 reference

14 October 2017

1 reference

14 October 2017

1 reference

14 October 2017

652-662

1 reference

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

New central targets for the treatment of obesity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

The histamine H3 receptor as a therapeutic drug target for CNS disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Minireview: Gut peptides: targets for antiobesity drug development?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Pharmacological treatment of the overweight patient

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Vaccination against weight gain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Effect of peptide YY3-36 on food intake in humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Common dietary supplements for weight loss.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Pancreatic polypeptide reduces appetite and food intake in humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Effects of growth hormone administration in human obesity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Adipose tissue mass can be regulated through the vasculature

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Phenylpropanolamine and the risk of hemorrhagic stroke

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Valvular heart disease associated with fenfluramine-phentermine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Sudden death associated with thyroid hormone abuse

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Aminorex and pulmonary hypertension. A review.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Anorectic and behavioural effects of bupropion

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136748

Endoplasmic reticulum stress plays a central role in development of leptin resistance

20 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

Angiogenic factors are elevated in overweight and obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

Rational design of a combination medication for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

Mortality rate in patients receiving "diet pills"

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20445536

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Growth hormone in obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.57

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.57

1 reference

Dimensions Publication ID

14 October 2017

0 references

1 reference

14 October 2017

PubMed publication ID

20445536

1 reference